The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A Rational Strategy to Design Multiepitope Immunogens Based on Multiple Th Lymphocyte Epitopes
Abstract
Four HLA-DR-restricted HIV-derived Th lymphocyte (HTL) epitopes cross-reactive with the murine I-Ab class II molecule were used to evaluate different vaccine design strategies to simultaneously induce multiple HTL responses. All four epitopes were immunogenic in H-2b mice, demonstrating the feasibility of murine models to evaluate epitope-based vaccines destined for human use. Immunization with a pool of peptides induced responses against all four epitopes; illustrating immunodominance does not prevent the induction of balanced multispecific responses. When different delivery systems were evaluated, a multiple Ag peptide construct was found to be less efficient than a linear polypeptide encompassing all four epitopes. Further characterization of linear polypeptide revealed that the sequential arrangement of the epitopes created a junctional epitope with high affinity class II binding. Disruption of this junctional epitope through the introduction of a GPGPG spacer restored the immunogenicity against all four epitopes. Finally, we demonstrate that a GPGPG spacer construct can be used to induce HTL responses by either polypeptide or DNA immunization, highlighting the flexibility of the approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A TH1→TH2 switch is a critical step in the etiology of HIV infection
Clerici, M., & Shearer, G. M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90208-3 · Cited by 1,390
Dominance and Crypticity of T Cell Antigenic Determinants
Sercarz, E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.729 · Cited by 855
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3363 · Cited by 665
Self-citationAlexander, J., Sidney, J., Southwood, S., Ruppert, J., Oseroff, C., Maewal, A., Snoke, K., Serra, H. M., Kubo, R. T., Sette, A., et al. (1994) · Immunity · doi:10.1016/s1074-7613(94)80017-0 · Cited by 523
Self-citationPromiscuous and allele-specific anchors in HLA-DR-binding peptides
Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., & Sinigaglia, F. (1993) · Cell · doi:10.1016/0092-8674(93)90306-b · Cited by 376
Wucherpfennig, K. W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J. L., & Hafler, D. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.279 · Cited by 322
Self-citationvon Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B., & Whitton, J. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1072-1079.1996 · Cited by 279
O’Sullivan, D., Arrhenius, T., Sidney, J., Del Guercio, M. F., Albertson, M., Wall, M., Oseroff, C., Southwood, S., Colón, S. M., & Gaeta, F. C. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2663 · Cited by 240
Self-citationFalk, K., R�tzschke, O., Stevanov�c, S., Jung, G., & Rammensee, H.-G. (1994) · Immunogenetics · doi:10.1007/bf00188785 · Cited by 228
Velders, M. P., Weijzen, S., Eiben, G. L., Elmishad, A. G., Kloetzel, P.-M., Higgins, T., Ciccarelli, R. B., Evans, M., Man, S., Smith, L., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5366 · Cited by 182
Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein
Disis, M. L., Gralow, J. R., Bernhard, H., Hand, S. L., Rubin, W. D., & Cheever, M. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3151 · Cited by 179
Guruprasad, K., & Rajkumar, S. (2000) · Journal of Biosciences · doi:10.1007/bf03404909 · Cited by 177
Tsai, V, Southwood, S., Sidney, J., Sakaguchi, K., Kawakami, Y., Appella, E., Sette, A., & Celis, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1796 · Cited by 175
Self-citationOptimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
Livingston, B. D., Newman, M. J., Crimi, C., McKinney, D. M., Chesnut, R. W., & Sette, A. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00233-x · Cited by 156
Self-citationThe role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1
Altfeld, M. A., & Rosenberg, E. S. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00103-5 · Cited by 150
Doolan, D. L., Southwood, S., Chesnut, R. W., Appella, E., Gomez, E., Richards, A. L., Higashimoto, Y., Maewal, A., Sidney, J., Gramzinski, R. A., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1123 · Cited by 131
Self-citationLivingston, B. D., Alexander, J., Crimi, C., Oseroff, C., Celis, E., Daly, K. R., Guidotti, L. G., Chisari, F. V., Fikes, J. D., Chesnut, R. W., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.3088 · Cited by 128
Self-citationHLA class II transgenic mice as models of human diseases
Taneja, V., & David, C. S. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01307.x · Cited by 97
Marsh, S. G. E., Parham, P., & Barber, L. D. (2000) · The HLA FactsBook · doi:10.1016/b978-012545025-6/50148-9 · Cited by 94
HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.
Geluk, A., van Meijgaarden, K. E., Southwood, S., Oseroff, C., Drijfhout, J. W., de Vries, R. R., Ottenhoff, T. H. M., & Sette, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.12.5742 · Cited by 82
Self-citationDISIS, SHIOTA, & Cheever (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00424.x · Cited by 54
Wall, K. A., Hu, J. Y., Currier, P., Southwood, S., Sette, A., & Infante, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4526 · Cited by 47
Self-citationAhlborg, N. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)00328-t · Cited by 32
Groot, A. S. D., Clerici, M., Hosmalin, A., Hughes, S. H., Barnd, D. L., Hendrix, C. W., Houghten, R. A., Shearer, G. M., & Berzofsky, J. A. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.6.1058 · Cited by 30
Joshi, M. B., Gam, A. A., Boykins, R. A., Kumar, S., Sacci, J. B., Hoffman, S. L., Nakhasi, H. L., & Kenney, R. T. (2001) · Infection and Immunity · doi:10.1128/iai.69.8.4884-4890.2001 · Cited by 29
Cited by
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
Macrophages as a therapeutic target to promote diabetic wound healing
Sharifiaghdam, M., Shaabani, E., Faridi-Majidi, R., De Smedt, S. C., Braeckmans, K., & Fraire, J. C. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.07.016 · Cited by 573
A novel multi-epitope peptide vaccine against cancer: An in silico approach
Nezafat, N., Ghasemi, Y., Javadi, G., Khoshnoud, M. J., & Omidinia, E. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.01.018 · Cited by 266
Metadata
- Authors
- Livingston, B., Crimi, C., Newman, M., Higashimoto, Y., Appella, E., Sidney, J., & Sette, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-06-01
- Volume
- 168
- Issue
- 11
- Pages
- 5499-5506
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2101340968
- Cited by
- 361
- References
- 25
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.